COLLEEN DOUGHERTY: Open Payments
NPI 1609392117 · JERMYN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 12 payments from 11 companies in 2025. Trend: 2023 $154 · 2024 $161 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $106 |
| Alkermes, Inc. | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Indivior Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Braeburn Inc. | 1 | $16 |
| Tandem Diabetes Care, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: ZEPBOUND, VIVITROL, REXULTI, SUBLOCADE, The Cologuard Plus Collection Kit, Veozah, PREVNAR 20, BRIXADI.
Industry payments across PA — which companies pay providers there.
